Laurion Capital Management LP - BRIDGEBIO PHARMA INC ownership

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$14,494,226
+23.1%
19,100,0000.0%0.09%
+33.3%
Q2 2023$11,771,71219,100,0000.07%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 20,000,000$8,393,0003.53%
INHERENT GROUP, LP 39,500,000$15,990,0002.52%
Affinity Asset Advisors, LLC 10,000,000$4,237,0001.79%
Diameter Capital Partners LP 69,500,000$27,974,0001.42%
DeepCurrents Investment Group LLC 39,355,000$18,072,0000.72%
Context Capital Management, LLC 16,458$6,726,0000.48%
ABSOLUTE INVESTMENT ADVISERS, LLC 5,000,000$2,052,0000.41%
Aequim Alternative Investments LP 31,000,000$13,135,0000.40%
ARISTEIA CAPITAL, L.L.C. 29,316,000$12,421,0000.22%
Orbimed Advisors 30,000,000$12,150,0000.22%
View complete list of BRIDGEBIO PHARMA INC shareholders